Darbepoetin alfa
Aranesp (darbepoetin alfa) is a protein pharmaceutical. Darbepoetin alfa was first approved as Aranesp on 2001-06-08. It is used to treat anemia in the USA. It has been approved in Europe to treat anemia, chronic kidney failure, and neoplasms.
| Trade Name | Aranesp |
|---|---|
| Common Name | Darbepoetin alfa |
| Indication | anemia, chronic kidney failure, neoplasms |
| Drug Class | Erythropoietins |
